Marina Sironi

Humanitas University — Italy

Immunology and Microbiology · Life Sciences

68h-index17.2kcitations278works2.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Response and Inflammation(61), Immune Cell Function and Interaction(44), Biomarkers in Disease Mechanisms(43), Immune cells in cancer(23), Cytokine Signaling Pathways and Interactions(22)

Publications278 total

787 RORγ bridges cancer-driven lipid dysmetabolism and myeloid immunosuppression
Regular and Young Investigator Award Abstracts·2025Open Access
Synovial MS4A4A correlates with inflammation and counteracts response to corticosteroids in arthritis
Proceedings of the National Academy of Sciences·2025Open Access
Figure S7 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025Open Access
Figure S2 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025Open Access
Figure S5 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025Open Access
Figure S9 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025Open Access
Table S5 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025Open Access
Table S3 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025Open Access
Figure S1 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025Open Access
Figure S8 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025Open Access
Data from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025Open Access
Table S2 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025Open Access
Table S4 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025Open Access
Figure S10 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025Open Access
Figure S11 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025Open Access
Table S1 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025Open Access
Figure S6 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025Open Access
Figure S3 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025Open Access
Figure S4 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025Open Access
Monocyte-macrophage membrane expression of IL-1R2 is a severity biomarker in sepsis
Cell Death and Disease·2025· 10 citedOpen Access
page 1 of 14Next →

Frequent Co-authors

Alberto Mantovani(35), Nadia Polentarutti(10), Silvano Sozzani(10), Cecília Garlanda(10), Annunciata Vecchi(10), Francesco Colotta(8), Pietro Ghezzi(7), Andrea Doni(6), Barbara Bottazzi(6), Massimo Locati(6), Walter Luini(5), Marta Muzio(5), Paola Allavena(4), Andrea Biondi(4), Jo Van Damme(4), Sergio Bernasconi(4), Raffaella Faggioni(3), Federico Bussolino(3), Fabio Re(3), Lorenzo Piemonti(3)